Antiviral activity of gemcitabine against human rhinovirus in vitro and in vivo

Antiviral Research

Volumn 145, Issue , 2017, Pages 6-13

  Song, Jae Hyoung ^a   Kim, Seong Ryeol ^a   Heo, Eun Young ^a   Lee, Jae Young ^a   Kim, Dong eun ^b   Cho, Sungchan ^b   Chang, Sun Young ^c   Yoon, Byung Il ^a   Seong, Jeongmin ^a   Ko, Hyun Jeong ^a,d  

^a Kangwon National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Ajou University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Antiviral drug; Gemcitabine; Inflammation; Proinflammatory cytokines; Rhinovirus

Indexed keywords

CYTIDINE TRIPHOSPHATE; GEMCITABINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR; URIDINE TRIPHOSPHATE; VIRUS RNA; ANTIVIRUS AGENT; CYTOKINE; DEOXYCYTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHINOVIRUS INFECTION; RNA REPLICATION; RNA SYNTHESIS; VIRUS LOAD; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; DRUG REPOSITIONING; IMMUNOLOGY; LUNG; PICORNAVIRUS INFECTION; RHINOVIRUS; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYTOKINES; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; DRUG REPOSITIONING; HUMANS; INFLAMMATION; LUNG; MICE; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 85023609037     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2017.07.003     Document Type: Article

References (37)

1. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., Glanville, N., Choy, K.J., Jourdan, P., Burnet, J., Tuthill, T.J., Pedrick, M.S., Hurle, M.J., Plumpton, C., Sharp, N.A., Bussell, J.N., Swallow, D.M., Schwarze, J., Guy, B., Almond, J.W., Jeffery, P.K., Lloyd, C.M., Papi, A., Killington, R.A., Rowlands, D.J., Blair, E.D., Clarke, N.J., Johnston, S.L., Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14 (2008), 199–204.
2. Basu, A., Li, B., Mills, D.M., Panchal, R.G., Cardinale, S.C., Butler, M.M., Peet, N.P., Majgier-Baranowska, H., Williams, J.D., Patel, I., Moir, D.T., Bavari, S., Ray, R., Farzan, M.R., Rong, L., Bowlin, T.L., Identification of a small-molecule entry inhibitor for filoviruses. J. Virol. 85 (2011), 3106–3119.
3. Bochkov, Y.A., Watters, K., Ashraf, S., Griggs, T.F., Devries, M.K., Jackson, D.J., Palmenberg, A.C., Gern, J.E., Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 5485–5490.
4. Choi, H.J., Kim, J.H., Lee, C.H., Ahn, Y.J., Song, J.H., Baek, S.H., Kwon, D.H., Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antivir. Res. 81 (2009), 77–81.
5. Choi, H.J., Song, H.H., Lee, J.S., Ko, H.J., Song, J.H., Inhibitory effects of norwogonin, oroxylin a, and mosloflavone on enterovirus 71. Biomol. Ther. 24 (2016), 552–558.
6. Corne, J.M., Marshall, C., Smith, S., Schreiber, J., Sanderson, G., Holgate, S.T., Johnston, S.L., Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet (Lond. Engl. 359 (2002), 831–834.
7. Daelemans, D., Pauwels, R., De Clercq, E., Pannecouque, C., A time-of-drug addition approach to target identification of antiviral compounds. Nat. Protoc. 6 (2011), 925–933.
8. Fendrick, A.M., Monto, A.S., Nightengale, B., Sarnes, M., The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives Intern. Med. 163 (2003), 487–494.
9. Friedlander, S.L., Busse, W.W., The role of rhinovirus in asthma exacerbations. J. Allergy Clin. Immunol. 116 (2005), 267–273.
10. Greenberg, S.B., Respiratory consequences of rhinovirus infection. Archives Intern. Med. 163 (2003), 278–284.
11. Hayden, F.G., Coats, T., Kim, K., Hassman, H.A., Blatter, M.M., Zhang, B., Liu, S., Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Antivir. Ther. 7 (2002), 53–65.
12. Hayden, F.G., Herrington, D.T., Coats, T.L., Kim, K., Cooper, E.C., Villano, S.A., Liu, S., Hudson, S., Pevear, D.C., Collett, M., McKinlay, M., Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 36 (2003), 1523–1532.
13. Hayden, F.G., Turner, R.B., Gwaltney, J.M., Chi-Burris, K., Gersten, M., Hsyu, P., Patick, A.K., Smith, G.J. 3rd, Zalman, L.S., Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob. Agents Chemother. 47 (2003), 3907–3916.
14. Heinemann, V., Schulz, L., Issels, R.D., Plunkett, W., Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism. Semin. Oncol. 22 (1995), 11–18.
15. Heinemann, V., Xu, Y.Z., Chubb, S., Sen, A., Hertel, L.W., Grindey, G.B., Plunkett, W., Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. Mol. Pharmacol. 38 (1990), 567–572.
16. Heinemann, V., Xu, Y.Z., Chubb, S., Sen, A., Hertel, L.W., Grindey, G.B., Plunkett, W., Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation. Cancer Res. 52 (1992), 533–539.
17. Hofer, F., Gruenberger, M., Kowalski, H., Machat, H., Huettinger, M., Kuechler, E., Blaas, D., Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 1839–1842.
18. Kang, H., Kim, C., Kim, D.E., Song, J.H., Choi, M., Choi, K., Kang, M., Lee, K., Kim, H.S., Shin, J.S., Kim, J., Han, S.B., Lee, M.Y., Lee, S.U., Lee, C.K., Kim, M., Ko, H.J., van Kuppeveld, F.J., Cho, S., Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses. Antivir. Res. 124 (2015), 1–10.
19. Kim, E., Lee, H., Kim, H.S., Won, S., Lee, E.K., Bang, K., Chun, Y.H., Yoon, J.S., Kim, H.H., Kim, J.T., Lee, J.S., The effect of rhinovirus on airway inflammation in a murine asthma model. Korean J. Pediatr. 56 (2013), 482–489.
20. Krenn, B.M., Holzer, B., Gaudernak, E., Triendl, A., van Kuppeveld, F.J., Seipelt, J., Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions. J. Virol. 79 (2005), 13892–13899.
21. Kwon, B.E., Song, J.H., Song, H.H., Kang, J.W., Hwang, S.N., Rhee, K.J., Shim, A., Hong, E.H., Kim, Y.J., Jeon, S.M., Chang, S.Y., Kim, D.E., Cho, S., Ko, H.J., Antiviral activity of oroxylin a against coxsackievirus B3 alleviates virus-induced acute pancreatic damage in mice. PloS One, 11, 2016, e0155784.
22. Lacroix, C., Laconi, S., Angius, F., Coluccia, A., Silvestri, R., Pompei, R., Neyts, J., Leyssen, P., In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. Virol. J., 12, 2015, 106.
23. Mehta, A.K., Duan, W., Doerner, A.M., Traves, S.L., Broide, D.H., Proud, D., Zuraw, B.L., Croft, M., Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. J. Allergy Clin. Immunol., 137(278–288), 2016, e276.
24. Newcomb, D.C., Sajjan, U.S., Nagarkar, D.R., Wang, Q., Nanua, S., Zhou, Y., McHenry, C.L., Hennrick, K.T., Tsai, W.C., Bentley, J.K., Lukacs, N.W., Johnston, S.L., Hershenson, M.B., Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am. J. Respir. Crit. Care Med. 177 (2008), 1111–1121.
25. Palmenberg, A.C., Rathe, J.A., Liggett, S.B., Analysis of the complete genome sequences of human rhinovirus. J. Allergy Clin. Immunol. 125 (2010), 1190–1199 quiz 1200–1191.
26. Palmenberg, A.C., Spiro, D., Kuzmickas, R., Wang, S., Djikeng, A., Rathe, J.A., Fraser-Liggett, C.M., Liggett, S.B., Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324 (2009), 55–59.
27. Patick, A.K., Rhinovirus chemotherapy. Antivir. Res. 71 (2006), 391–396.
28. Patick, A.K., Binford, S.L., Brothers, M.A., Jackson, R.L., Ford, C.E., Diem, M.D., Maldonado, F., Dragovich, P.S., Zhou, R., Prins, T.J., Fuhrman, S.A., Meador, J.W., Zalman, L.S., Matthews, D.A., Worland, S.T., In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 43 (1999), 2444–2450.
29. Roelen, C.A., Koopmans, P.C., Notenbomer, A., Groothoff, J.W., Job satisfaction and short sickness absence due to the common cold. Work Read.g, Mass.) 39 (2011), 305–313.
30. Ross, D.D., Cuddy, D.P., Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells. Biochem. Pharmacol. 48 (1994), 1619–1630.
31. Shannon, W.M., Arnett, G., Schabel, F.M. Jr., 3-Deazauridine: inhibition of ribonucleic acid virus-induced cytopathogenic effects in vitro. Antimicrob. Agents Chemother. 2 (1972), 159–163.
32. Shim, A., Song, J.H., Kwon, B.E., Lee, J.J., Ahn, J.H., Kim, Y.J., Rhee, K.J., Chang, S.Y., Cha, Y., Lee, Y.S., Kweon, M.N., Park, K.S., Kim, D.E., Cho, S., Cho, H.J., Ko, H.J., Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model. Sci. Rep., 6, 2016, 23110.
33. Slater, L., Bartlett, N.W., Haas, J.J., Zhu, J., Message, S.D., Walton, R.P., Sykes, A., Dahdaleh, S., Clarke, D.L., Belvisi, M.G., Kon, O.M., Fujita, T., Jeffery, P.K., Johnston, S.L., Edwards, M.R., Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog., 6, 2010, e1001178.
34. Staunton, D.E., Merluzzi, V.J., Rothlein, R., Barton, R., Marlin, S.D., Springer, T.A., A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56 (1989), 849–853.
35. Underwood, S., Foster, M., Raeburn, D., Bottoms, S., Karlsson, J.A., Time-course of antigen-induced airway inflammation in the Guinea-pig and its relationship to airway hyperresponsiveness. Eur. Respir. J. 8 (1995), 2104–2113.
36. Winther, B., Rhinovirus infections in the upper airway. Proc. Am. Thorac. Soc. 8 (2011), 79–89.
37. Zeichhardt, H., Otto, M.J., McKinlay, M.A., Willingmann, P., Habermehl, K.O., Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology 160 (1987), 281–285.